Photobiomodulation (Red and Near-Infrared Light)
This article is a placeholder. Only its topic and title are committed at this stage; the substantive body will be drafted in a future cycle of the engine.
Targeted exposure to 600–900 nm light for mitochondrial-CCO mechanism effects on skin, brain (via Vielight intranasal devices), muscle recovery, and inflammation. The Hamblin literature anchors the mechanism; the consumer-device evidence base is scattered, with dose, wavelength, and duration as the active variables most marketing copy obscures.